Search

everythinglearnresearchcommunity

for

Search:↓

Overexpressing PKCα in mice skin increases inflammation but doesn't affect tumor growth.

Inhibiting TYK2 can restore hair growth in alopecia areata.

17β-estradiol can reduce inflammation in the skin.

A specific RNA increases hair stem cell growth and skin healing by affecting a protein through interaction with a microRNA.

Decreased IGF-1R expression may contribute to sacrococcygeal pilonidal sinus development.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

The LEF-1 gene in cashmere goats was successfully cloned and analyzed, showing potential for improving cashmere production.

Retinol may affect immune responses in people with frequent skin boils.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Inflammation damages sweat ducts, causing sweat gland injury.

Herbal extract may help treat certain types of hair loss.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Blocking α1-integrin makes adult fibroblasts more like foetal ones, improving their movement and aiding wound healing.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

GLI2 increases follistatin production in human skin cells.

Targeting LPA could help treat skin disorders.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.